CIP2A confirms its prognostic value in triple-negative breast cancer.
Oncogene
; 36(23): 3357-3358, 2017 06 08.
Article
in En
| MEDLINE
| ID: mdl-28068327
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cell Line, Tumor
/
Triple Negative Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Oncogene
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2017
Document type:
Article
Affiliation country:
Spain
Publication country:
ENGLAND
/
ESCOCIA
/
GB
/
GREAT BRITAIN
/
INGLATERRA
/
REINO UNIDO
/
SCOTLAND
/
UK
/
UNITED KINGDOM